KDM6B and leukemia: Furthermore, upregulation of JMJD3 by nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) contributes to inflammatory diseases, with knockdown of JMJD3 in human leukemia monocytes suppressing chemokine and NF-κB-related inflammatory gene expression [28].